Lynn VerPlank

2.1k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Lynn VerPlank is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Lynn VerPlank has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in Lynn VerPlank's work include Platelet Disorders and Treatments (3 papers), Cancer Cells and Metastasis (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Lynn VerPlank is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Cancer Cells and Metastasis (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Lynn VerPlank collaborates with scholars based in United States, Poland and France. Lynn VerPlank's co-authors include Rong Li, Fadila Bouamr, Carol A. Carter, Tracy J. LaGrassa, Alexandra Kikonyogo, Jonathan Leis, Nicola Tolliday, Peter J. Bruns, Martin A. Gorovsky and Eric S. Cole and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Lynn VerPlank

18 papers receiving 1.4k citations

Hit Papers

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
    2001 501 citations Lynn VerPlank, Fadila Bouamr et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn VerPlank United States 14 864 411 322 162 149 18 1.5k
Mark Andrake United States 21 1.5k 1.8× 132 0.3× 370 1.1× 455 2.8× 123 0.8× 55 2.1k
Thomas Wollert France 14 1.4k 1.6× 918 2.2× 99 0.3× 91 0.6× 85 0.6× 26 2.1k
Erik Martı́nez-Hackert United States 21 1.4k 1.6× 103 0.3× 44 0.1× 120 0.7× 447 3.0× 35 2.1k
Yun Bai China 18 1.4k 1.6× 91 0.2× 102 0.3× 84 0.5× 80 0.5× 33 1.8k
Joshua L. Andersen United States 20 784 0.9× 133 0.3× 322 1.0× 178 1.1× 52 0.3× 32 1.3k
Robert A. Boykins United States 20 772 0.9× 362 0.9× 100 0.3× 66 0.4× 92 0.6× 34 1.6k
Lyndall J. Briggs Australia 15 936 1.1× 95 0.2× 95 0.3× 106 0.7× 213 1.4× 21 1.3k
Shozo Shoji Japan 19 636 0.7× 112 0.3× 227 0.7× 169 1.0× 60 0.4× 73 971
Seng‐Lai Tan United States 24 800 0.9× 90 0.2× 116 0.4× 329 2.0× 95 0.6× 36 2.4k
Deli Huang United States 19 1.8k 2.1× 136 0.3× 75 0.2× 876 5.4× 132 0.9× 28 2.9k

Countries citing papers authored by Lynn VerPlank

Since Specialization
Citations

This map shows the geographic impact of Lynn VerPlank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn VerPlank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn VerPlank more than expected).

Fields of papers citing papers by Lynn VerPlank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn VerPlank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn VerPlank. The network helps show where Lynn VerPlank may publish in the future.

Co-authorship network of co-authors of Lynn VerPlank

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn VerPlank. A scholar is included among the top collaborators of Lynn VerPlank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn VerPlank. Lynn VerPlank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bageshwar, Umesh K., Lynn VerPlank, Dwight Baker, et al.. (2016). High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors. PLoS ONE. 11(2). e0149659–e0149659. 18 indexed citations
2.
Duvall, Jeremy R., Lynn VerPlank, Barbara Ludeke, et al.. (2016). Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen. Antiviral Research. 131. 19–25. 11 indexed citations
3.
Zielonka, Jacek, Monika Zielonka, Lynn VerPlank, et al.. (2016). Mitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation. Journal of Biological Chemistry. 291(13). 7029–7044. 59 indexed citations
4.
Olabisi, Opeyemi A., Lynn VerPlank, Nathan H. Zahler, et al.. (2015). APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proceedings of the National Academy of Sciences. 113(4). 830–837. 153 indexed citations
5.
Khodier, Carol, Lynn VerPlank, Partha P. Nag, et al.. (2014). Identification of ML359 as a Small Molecule Inhibitor of Protein Disulfide Isomerase. 16 indexed citations
6.
Wurst, Jacqueline, Eric J. Drake, Jimmy R. Thériault, et al.. (2014). Identification of Inhibitors of PvdQ, an Enzyme Involved in the Synthesis of the Siderophore Pyoverdine. ACS Chemical Biology. 9(7). 1536–1544. 33 indexed citations
7.
Frumm, Stacey M., Zi Peng Fan, Kenneth N. Ross, et al.. (2013). Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation. Chemistry & Biology. 20(5). 713–725. 85 indexed citations
8.
Germain, Andrew, Leigh Carmody, Partha P. Nag, et al.. (2013). Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters. 23(6). 1834–1838. 14 indexed citations
9.
Thériault, Jimmy R., Jacqueline Wurst, Lynn VerPlank, et al.. (2013). Identification of a small molecule inhibitor of Pseudomonas aeruginosa PvdQ acylase, an enzyme involved in siderophore pyoverdine synthesis. Europe PMC (PubMed Central). 6 indexed citations
10.
Germain, Andrew, Leigh Carmody, Barbara J. Morgan, et al.. (2012). Identification of a selective small molecule inhibitor of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters. 22(10). 3571–3574. 31 indexed citations
11.
Carmody, Leigh, Andrew Germain, Lynn VerPlank, et al.. (2012). Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like Cells. SLAS DISCOVERY. 17(9). 1204–1210. 28 indexed citations
12.
Dockendorff, Chris, Omozuanvbo Aisiku, Lynn VerPlank, et al.. (2012). Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor. ACS Medicinal Chemistry Letters. 3(3). 232–237. 33 indexed citations
13.
VerPlank, Lynn, Chris Dockendorff, Joseph Negri, et al.. (2011). Chemical Genetic Analysis of Platelet Granule Secretion-Probe 1. 3 indexed citations
14.
Flaumenhaft, Robert, Lynn VerPlank, James R. Dilks, et al.. (2010). Identification of a Novel Par1 inhibitor Using a Chemical Genetic Screen. Blood. 116(21). 2018–2018. 1 indexed citations
15.
VerPlank, Lynn & Rong Li. (2005). Cell Cycle-regulated Trafficking of Chs2 Controls Actomyosin Ring Stability during Cytokinesis. Molecular Biology of the Cell. 16(5). 2529–2543. 106 indexed citations
16.
Tolliday, Nicola, Lynn VerPlank, & Rong Li. (2002). Rho1 Directs Formin-Mediated Actin Ring Assembly during Budding Yeast Cytokinesis. Current Biology. 12(21). 1864–1870. 120 indexed citations
17.
VerPlank, Lynn, Fadila Bouamr, Tracy J. LaGrassa, et al.. (2001). Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag. Proceedings of the National Academy of Sciences. 98(14). 7724–7729. 501 indexed citations breakdown →
18.
Cassidy-Hanley, Donna, Josephine Bowen, John H. Lee, et al.. (1997). Germline and Somatic Transformation of Mating Tetrahymena thermophila by Particle Bombardment. Genetics. 146(1). 135–147. 243 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Andrake Breakdown of academic impact, for papers by Thomas Wollert Breakdown of academic impact, for papers by Erik Martı́nez-Hackert Breakdown of academic impact, for papers by Yun Bai Breakdown of academic impact, for papers by Joshua L. Andersen Breakdown of academic impact, for papers by Robert A. Boykins Breakdown of academic impact, for papers by Lyndall J. Briggs Breakdown of academic impact, for papers by Shozo Shoji Breakdown of academic impact, for papers by Seng‐Lai Tan Breakdown of academic impact, for papers by Deli Huang
Rankless by CCL
2026